Table 6.

SES and baseline disease characteristics of ASCC patients by HIV Status

SES factor or covariate	HIV‐positive total (%) n = 52	HIV‐negative total (%) n = 59	P‐value
Race
Majority	29 (39.2)	45 (60.8)	.022
Minority	23 (62.2)	14 (37.8)
Income level
Low	15 (71.4)	6 (28.6)	.018
Middle	16 (36.4)	28 (63.6)
Upper	9 (36.0)	16 (64.0)
Employment status
Employed or retired	17 (27.9)	44 (72.1)	<.001
Unemployed or disabled	32 (72.7)	12 (27.3)
Partnership status
Partnered	14 (40.0)	21 (60.0)	.213
Unpartnered	36 (52.9)	32 (47.1)
Primary payer
Private	12 (35.3)	22 (64.7)	.001
Medicaid	30 (61.2)	19 (38.8)
Medicare	3 (14.3)	18 (85.7)
Age, median (IQR)	54.0 (49.2‐57.0)	62.7 (55.5‐68.5)	<.001
Gender
Male	50 (65.8)	26 (34.2)	<.001
Female	2 (5.7)	33 (94.3)
TN stage
T1/T2, N‐negative	28 (53.8)	24 (46.2)	.382
T1/T2, N‐positive and T3/T4, N‐negative	17 (40.5)	25 (59.5)
T3/T4, N‐positive	7 (41.2)	10 (58.8)

Frequencies were compared between groups using Pearson's Chi‐square for categorical predictor variables and the t test for age.

Abbreviations: ASCC, anal squamous cell carcinoma; IQR, interquartile range; SES, socioeconomic status; TN, tumor‐node.